stolaney1.bsky.social
Chief, Division of Breast Oncology Dana-Farber Cancer Institute
👤 Joined on 26 November 2024
Followers
Following
Total Posts
@stolaney1.bsky.socialAACR Announces 2025 Breast Cancer Research Award Recipients Ahead of SABCS 2025 @theaacr.bsky.social @sabcs.bsky.social @stolaney1.bsky.social oncodaily.com/industry/aac... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR #BreastCancer #SABCS #SABCS2025
Show PostDon't miss this recent review outlining practical treatment strategies and novel therapies in the PI3K/AKT/mTOR pathway in HR+/HER2- advanced #BreastCancer 🔓 pubmed.ncbi.nlm.nih.gov/39674130/ @antgiordanomd.bsky.social @drtimothyerick.bsky.social @stolaney1.bsky.social @drsarahsammons.bsky.social
Show PostCongratulations all!! @stolaney1.bsky.social @lymphomadoc.bsky.social @ryannipp.bsky.social and more! #FASCO
Show Post📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer. 🔓https://pubmed.ncbi.nlm.nih.gov/39908010/ @drtimothyerick.bsky.social @nlinmd.bsky.social @stolaney1.bsky.social
Show Postvery important (but negative) trial on cdk46i in mTNBC. huge shout-out to @stolaney1.bsky.social and Shom Goel for conducting this trial👍 @oncoalert.bsky.social #bcsm
Show Post